Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial

PaperCitations, authors & open-access status

Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 148 citations, 2021 year and hybrid oa status.

148
Citations
2021
Year
hybrid
OA Status

Related on ScholarIQ

Ying Cheng
Author
Te‐Chun Hsia
Author
James Chih‐Hsin Yang
Author
Journal of Thoracic Oncology
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account